Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

The cytokine IL-17A as a marker of treatment resistance in major depressive disorder?

Nothdurfter C, Milenkovic VM, Sarubin N, Hilbert S, Manook A, Weigl J, Almeqbaali K, Wetzel CH, Rupprecht R, Baghai TC.

Eur J Neurosci. 2019 Dec 2. doi: 10.1111/ejn.14636. [Epub ahead of print]

PMID:
31793127
2.

CRISPR-Cas9 Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells.

Milenkovic VM, Slim D, Bader S, Koch V, Heinl ES, Alvarez-Carbonell D, Nothdurfter C, Rupprecht R, Wetzel CH.

Int J Mol Sci. 2019 Jul 9;20(13). pii: E3359. doi: 10.3390/ijms20133359.

3.

The Role of Chemokines in the Pathophysiology of Major Depressive Disorder.

Milenkovic VM, Stanton EH, Nothdurfter C, Rupprecht R, Wetzel CH.

Int J Mol Sci. 2019 May 9;20(9). pii: E2283. doi: 10.3390/ijms20092283. Review.

4.

Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells.

Bader S, Wolf L, Milenkovic VM, Gruber M, Nothdurfter C, Rupprecht R, Wetzel CH.

Psychoneuroendocrinology. 2019 Aug;106:65-76. doi: 10.1016/j.psyneuen.2019.03.029. Epub 2019 Mar 29.

PMID:
30954920
5.

Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular Disease and Major Depressive Disorder.

Baghai TC, Varallo-Bedarida G, Born C, Häfner S, Schüle C, Eser D, Zill P, Manook A, Weigl J, Jooyandeh S, Nothdurfter C, von Schacky C, Bondy B, Rupprecht R.

Int J Mol Sci. 2018 Jun 12;19(6). pii: E1740. doi: 10.3390/ijms19061740.

6.

Effects of genetic variants in the TSPO gene on protein structure and stability.

Milenkovic VM, Bader S, Sudria-Lopez D, Siebert R, Brandl C, Nothdurfter C, Weber BHF, Rupprecht R, Wetzel CH.

PLoS One. 2018 Apr 11;13(4):e0195627. doi: 10.1371/journal.pone.0195627. eCollection 2018.

7.

Macrophage-Derived Chemokine: A Putative Marker of Pharmacological Therapy Response in Major Depression?

Milenkovic VM, Sarubin N, Hilbert S, Baghai TC, Stöffler F, Lima-Ojeda JM, Manook A, Almeqbaali K, Wetzel CH, Rupprecht R, Nothdurfter C.

Neuroimmunomodulation. 2017;24(2):106-112. doi: 10.1159/000479739. Epub 2017 Sep 13.

PMID:
28898872
8.

The sex-dependent role of the glucocorticoid receptor in depression: variations in the NR3C1 gene are associated with major depressive disorder in women but not in men.

Sarubin N, Hilbert S, Naumann F, Zill P, Wimmer AM, Nothdurfter C, Rupprecht R, Baghai TC, Bühner M, Schüle C.

Eur Arch Psychiatry Clin Neurosci. 2017 Mar;267(2):123-133. doi: 10.1007/s00406-016-0722-5. Epub 2016 Aug 22.

PMID:
27549215
9.

The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial.

Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, Zimmermannc R, Bühner M, Konopka K, Rupprecht R, Baghai TC.

J Psychiatr Res. 2014 Jun;53:76-83. doi: 10.1016/j.jpsychires.2014.02.022. Epub 2014 Mar 11.

PMID:
24655586
10.

Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.

Nothdurfter C, Schmotz C, Sarubin N, Baghai TC, Laenger A, Lieb M, Bondy B, Rupprecht R, Schüle C.

J Psychiatr Res. 2014 May;52:15-20. doi: 10.1016/j.jpsychires.2014.01.013. Epub 2014 Jan 31.

PMID:
24513501
11.

Translocator protein (18 kDa) (TSPO) is expressed in reactive retinal microglia and modulates microglial inflammation and phagocytosis.

Karlstetter M, Nothdurfter C, Aslanidis A, Moeller K, Horn F, Scholz R, Neumann H, Weber BH, Rupprecht R, Langmann T.

J Neuroinflammation. 2014 Jan 8;11:3. doi: 10.1186/1742-2094-11-3.

12.

Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression.

Sarubin N, Nothdurfter C, Schmotz C, Wimmer AM, Trummer J, Lieb M, Uhr M, Baghai TC, Wetter TC, Bühner M, Rupprecht R, Schüle C.

Psychoneuroendocrinology. 2014 Jan;39:141-51. doi: 10.1016/j.psyneuen.2013.10.008. Epub 2013 Oct 23.

PMID:
24275013
13.

The role of allopregnanolone in depression and anxiety.

Schüle C, Nothdurfter C, Rupprecht R.

Prog Neurobiol. 2014 Feb;113:79-87. doi: 10.1016/j.pneurobio.2013.09.003. Epub 2013 Nov 8. Review.

PMID:
24215796
14.

Pharmacological challenge with naloxone and cue exposure in alcohol dependence: results of a randomized, double-blind placebo-controlled trial.

Lieb M, Palm U, Chiang S, Laubender RP, Nothdurfter C, Sarubin N, Mokhtari-Nejad R, Koller G, Soyka M.

World J Biol Psychiatry. 2013 Sep;14(7):539-46. doi: 10.3109/15622975.2013.812239.

PMID:
24020866
15.

Tryptophan metabolism and immunogenetics in major depression: a role for interferon-γ gene.

Myint AM, Bondy B, Baghai TC, Eser D, Nothdurfter C, Schüle C, Zill P, Müller N, Rupprecht R, Schwarz MJ.

Brain Behav Immun. 2013 Jul;31:128-33. doi: 10.1016/j.bbi.2013.04.003. Epub 2013 Apr 15.

PMID:
23597432
16.

Lipid raft integrity affects GABAA receptor, but not NMDA receptor modulation by psychopharmacological compounds.

Nothdurfter C, Tanasic S, Di Benedetto B, Uhr M, Wagner EM, Gilling KE, Parsons CG, Rein T, Holsboer F, Rupprecht R, Rammes G.

Int J Neuropsychopharmacol. 2013 Jul;16(6):1361-71. doi: 10.1017/S146114571200140X. Epub 2012 Dec 10.

17.

Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.

Nothdurfter C, Baghai TC, Schüle C, Rupprecht R.

Eur Arch Psychiatry Clin Neurosci. 2012 Nov;262 Suppl 2:S107-12. doi: 10.1007/s00406-012-0352-5. Epub 2012 Aug 26. Review.

PMID:
22923187
18.

Lack of association of the 5-HT(3A) receptor with schizophrenia.

Nothdurfter C, Giegling I, Konte B, Hartmann AM, Konnerth H, Friedl M, Rammes G, Rupprecht R, Rujescu D.

Am J Med Genet B Neuropsychiatr Genet. 2012 Apr;159B(3):310-5. doi: 10.1002/ajmg.b.32028. Epub 2012 Feb 10.

PMID:
22328445
19.

Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO).

Nothdurfter C, Rupprecht R, Rammes G.

Curr Top Med Chem. 2012;12(4):360-70. Review.

PMID:
22204486
20.

N-desalkylquetiapine activates ERK1/2 to induce GDNF release in C6 glioma cells: a putative cellular mechanism for quetiapine as antidepressant.

Di Benedetto B, Kühn R, Nothdurfter C, Rein T, Wurst W, Rupprecht R.

Neuropharmacology. 2012 Jan;62(1):209-16. doi: 10.1016/j.neuropharm.2011.07.001. Epub 2011 Jul 13.

PMID:
21767553

Supplemental Content

Loading ...
Support Center